Comments
Loading...
Arcturus Therapeutics (ARCT) Forecast
NewsEarningsArcturus Therapeutics (ARCT) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestArcturus Therapeutics (NASDAQ:ARCT) Stock Quotes, Forecast and News Summary
Arcturus Therapeutics Stock (NASDAQ: ARCT) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Arcturus Therapeutics (ARCT) stock?
You can purchase shares of Arcturus Therapeutics (NASDAQ:ARCT) through any online brokerage.
Who are Arcturus Therapeutics (ARCT) competitors?
There are no as such competitors for Arcturus Therapeutics.
What is the forecast, or price target, for Arcturus Therapeutics (ARCT) stock?
Arcturus Therapeutics has a consensus price target of $50.18.
What is the current price for Arcturus Therapeutics (ARCT)?
The stock price for Arcturus Therapeutics (NASDAQ: ARCT) is $17.35 last updated January 27, 2025 at 8:43 AM EST.
Does Arcturus Therapeutics (ARCT) pay a dividend?
There are no upcoming dividends for Arcturus Therapeutics.
When is Arcturus Therapeutics (NASDAQ:ARCT) reporting earnings?
Arcturus Therapeutics’s Q4 earnings are confirmed for Thursday, March 6, 2025.
Is Arcturus Therapeutics (ARCT) going to split?
There is no upcoming split for Arcturus Therapeutics.
What sector and industry does Arcturus Therapeutics (ARCT) operate in?
Arcturus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.